Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats (2008)
- Authors:
- USP affiliated authors: SANTOS, JOSE EDUARDO TANUS DOS - FMRP ; BENDHACK, LUSIANE MARIA - FCFRP ; GERLACH, RAQUEL FERNANDA - FORP
- Unidades: FMRP; FCFRP; FORP
- DOI: 10.1016/j.ejphar.2008.10.007
- Subjects: DIABETES MELLITUS; METALOPROTEINASES; DOENÇAS CARDIOVASCULARES; ESTRESSE OXIDATIVO
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Pharmacology
- ISSN: 0014-2999
- Volume/Número/Paginação/Ano: v. 599, n. 1-3, p. 110-116, 2008
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
MARTINEZ, Marcio L. L. et al. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, v. 599, n. 1-3, p. 110-116, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.10.007. Acesso em: 07 maio 2026. -
APA
Martinez, M. L. L., Rizzi, E., Castro, M. M., Fernandes, K., Bendhack, L. M., Gerlach, R. F., & Tanus-Santos, J. E. (2008). Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, 599( 1-3), 110-116. doi:10.1016/j.ejphar.2008.10.007 -
NLM
Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2026 maio 07 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007 -
Vancouver
Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2026 maio 07 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007 - Intraluminal administration of matrix metalloproteinase 2 (MMP-2) increases vascular oxidative stress and the vasoconstriction induced by phenylephrine in rabbit aortic rings
- Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats
- Increased activity of matrix metalloproteinase-2(MMP-2) induced by reactive oxygen species (ROS) in two-kidney one-clip (2K1C) hypertension
- Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats
- Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability
- Metalloproteinase inhibition ameliorates hypertension and reverses vascular dysfunction and remodeling in renovascular hypertensive rats
- Evaluation of aortic metalloproteinase-2 (MMP-2) activity in two kidney one clip (2K1C) hypertension rats
- Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension
- Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses
- Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
